<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04156724</url>
  </required_header>
  <id_info>
    <org_study_id>C108032</org_study_id>
    <nct_id>NCT04156724</nct_id>
  </id_info>
  <brief_title>Helmet Ventilation During Walking Test</brief_title>
  <official_title>Helmet Ventilation During Walking Test With Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fu Jen Catholic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fu Jen Catholic University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow
      limitation with chronic inflammation of the respiratory system. Symptoms of COPD may
      contribute to activity restriction, deconditioning and exercise intolerance. Non-invasive
      positive pressure ventilation (NIPPV) has been shown to improve exercise intolerance and
      health-related quality of life in patients with severe COPD. Helmet ventilation (HV) is a new
      option for NIPPV to alternative to nasal or face mask. A study which published on JAMA
      demonstrated the feasibility and benefits of HV. The aim of this study is to investigate the
      use helmet ventilation (HV) in walking test and analysis of effect patients with COPD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 14, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6WMD</measure>
    <time_frame>2 days</time_frame>
    <description>Walking distance of six minute walking test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>2 days</time_frame>
    <description>Heart rate of six minute walking test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>2 days</time_frame>
    <description>Respiratory rate of six minute walking test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified Borg dyspnea scale</measure>
    <time_frame>2 days</time_frame>
    <description>A self report level of dyspnea score ranging from 0 to 10, 0 represent no dyspnea and 10 represents the worse</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>HV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6MWT with helmet ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>6MWT alone according to ATS guideline</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Helmet vetilation</intervention_name>
    <description>We will apply non-invasive positive pressure ventilation via a helmet as interface</description>
    <arm_group_label>HV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patents with COPD who confirm by pulmonary function test

        Exclusion Criteria:

          -  COPD AE within 3 months

          -  Diagnosed neuromuscular disease

          -  Unable to perform 6-MWT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fu Jen Catholic University Hospital, Fu Jen Catholic University</name>
      <address>
        <city>New Taipei City</city>
        <zip>24352</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ke-Yun Chao, M.Sc</last_name>
      <phone>+886952909103</phone>
      <email>ck_qq@hotmail.con</email>
    </contact>
    <investigator>
      <last_name>Ke-Yun Chao, M.Sc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Patel BK, Wolfe KS, Pohlman AS, Hall JB, Kress JP. Effect of Noninvasive Ventilation Delivered by Helmet vs Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA. 2016 Jun 14;315(22):2435-41. doi: 10.1001/jama.2016.6338.</citation>
    <PMID>27179847</PMID>
  </reference>
  <reference>
    <citation>Patel BK, Wolfe KS, MacKenzie EL, Salem D, Esbrook CL, Pawlik AJ, Stulberg M, Kemple C, Teele M, Zeleny E, Macleod J, Pohlman AS, Hall JB, Kress JP. One-Year Outcomes in Patients With Acute Respiratory Distress Syndrome Enrolled in a Randomized Clinical Trial of Helmet Versus Facemask Noninvasive Ventilation. Crit Care Med. 2018 Jul;46(7):1078-1084. doi: 10.1097/CCM.0000000000003124.</citation>
    <PMID>29595563</PMID>
  </reference>
  <reference>
    <citation>Dreher M, Storre JH, Windisch W. Noninvasive ventilation during walking in patients with severe COPD: a randomised cross-over trial. Eur Respir J. 2007 May;29(5):930-6. Epub 2007 Mar 1.</citation>
    <PMID>17331969</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>November 6, 2019</study_first_submitted>
  <study_first_submitted_qc>November 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2019</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fu Jen Catholic University</investigator_affiliation>
    <investigator_full_name>Ke-Yun, Chao</investigator_full_name>
    <investigator_title>Leader of Respiratory Therapist</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

